Navigation Links
Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Date:8/20/2007

aring two dose levels of OxyADF Tablets to placebo. Study medication will be administered to patients every six hours for 48 hours following the onset of moderate to severe pain following bunionectomy surgery. Study 105 is targeted to enroll 135 patients per arm (approximately 405 patients in total). As previously announced, the Company executed a Clinical Trial Development Agreement with a leading Contract Research Organization and commenced preliminary Study 105 start-up activities. However, initiation of patient enrollment in Study 105 remained dependent upon the availability of adequate funding. Now that new funding has been secured, the Company intends to proceed with patient enrollment in Study 105. The Company believes the completion of Study 105 is the critical time and events path to a 505(b)(2) NDA submission for OxyADF Tablets.

About Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in research, development and manufacture of innovative Aversion(R) (abuse deterrent) Technology and related product candidates.

Forward Looking Statements

This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the Company's expectations and projections. The most significant of such risks and uncertainties include, but are not limited to, the Company's ability to secure additional financing to fund operations, the Company's ability to enter into contractual arrangements with qualified pharmaceutical partners to license, develop and commercialize the Company's technology and product candidates, the Company's ability to avoid infringement of patents, trademarks and other proprietary rights or trade secrets of third parties, and the Company
'/>"/>

SOURCE Acura Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

2

GOOD

Page: 1 2 3

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
2. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
3. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
4. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data at Society Of Nuclear Medicine 2007 Annual Meeting
5. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
6. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
7. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
8. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
9. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
10. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
11. Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Dec. 14 Perry Baromedical, international leader ... the launch of the Sigma Elite, with extended ... the Sigma Elite is available on each monoplace ... has a Patent Pending. ,, The Sigma Elite ... Capture Via Computerized System for Each Dive ...
(Date:12/14/2009)... -- Sword Diagnostics, Inc. is pleased to announce ... has issued patent number 7,599,057 titled "Method and ... Scattering" to the company. The patent covers the ... ,, "The issuance of this patent supports the ... continued development and commercialization," said Dave Dingott, CEO ...
(Date:12/14/2009)... health advocates hope that U.S. FDA will make ... A (BPA), a synthetic sex hormone linked to ... in time for Christmas. ,, Sarah Janssen ... Natural Resources Defense Council : "Just as you ... must rely on the advice of scientific experts. ...
Breaking Medicine Technology:Perry Baromedical Announces New Cutting Edge Technology With Patient Data Capture Capability 2Toxic Chemical bisphenol A Still Not Banned By FDA; Schumer, Gillibrand Call for Ban; Govt Official Warns Public 2Access to U S Burn Centers Varies by Region 60186 1Access to U S Burn Centers Varies by Region 60186 2More Swine Flu Vaccine Coming Soon 60183 1More Swine Flu Vaccine Coming Soon 60183 2More Swine Flu Vaccine Coming Soon 60183 3Section 1803 3A Senate Health Care Bill Makes Planned Parenthood Quasi Government Agency 3F Asks ALL 60180 1Section 1803 3A Senate Health Care Bill Makes Planned Parenthood Quasi Government Agency 3F Asks ALL 60180 2
... Awareness and Bring Hope to Millions,of Children in ... children,across the globe are without parental care due ... disease. SOS Children,s Villages-USA (SOS-USA) is,observing World Orphan ... orphans,worldwide., To view the Multimedia News Release, ...
... October 9 Diamyd Medical reports,that the world,s most ... published an article with results from the company,s study,of ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080314/297194 ), The article is ... and will be in print on October 30. It ...
Other Medicine Technology:Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4
(Date:12/14/2009)... might lead to better treatments for asthma, COPD, researchers ... have identified five genetic variants that influence lung function, ... for lung diseases. , The international team of researchers ... the 2.5 million sites across the human genome in ... the team to the five common genetic variants associated ...
(Date:12/14/2009)... Lesions Quickly and Accurately for Biopsy , ... ... Dilon Diagnostics announced today that the U.S. Food and ... system for molecular imaging biopsy guidance. , , ,GammaLMc® ... 6800 Gamma Camera. The GammaLMc® (GL) system will help doctors ...
(Date:12/14/2009)... Ensure Health Workforce Recommendations are Implemented ... leaders must ensure that health reform includes ... authority to ensure implementation of an integrated, ... Dr. Steven A Wartman, president and CEO ... (AAHC). "With each step in the ...
(Date:12/14/2009)... Josie Raper, a 29 year-old mother from Phoenix ... with the help of the Dr. Siegal,s COOKIE DIET® six-cookies-a-day ... Fit Club segment on NBC,s Today Show. The Joy Fit ... twice a month and salutes those who have lost at ... has kept it off for two years. ,, "The first ...
(Date:12/14/2009)... Regents will be asked to approve naming the women,s ... and Women,s Hospital complex -- after Ted and Jane ... The University of Michigan Health System has ... Jane Von Voigtlander Foundation, the largest gift ever made ... support the construction of a new women,s hospital. ,, ...
Breaking Medicine News(10 mins):Health News:Dilon Diagnostics Gamma-Guided Localization System Cleared by FDA 2Health News:Health Reform Needs Enforceable National Workforce Strategy 2Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 2Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 3Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 4Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 2Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 3Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 4Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 5
... feelings about Clinton, BOSTON, April 3, 2008 ... they are typically willing,to admit, according to newly released ... express about the U.S. Senator from New,York does not ... appear to be,very deep., Emotion Mining, a Massachusetts ...
... CHICAGO, April 3, 2008 Recognizing the,escalating number ... has,awarded two grants to the Alzheimer,s Association, totaling ... and training for,emergency responders who encounter those with ... a longtime funder of research, advocacy,and programming around ...
... April 3, 2008 /PRNewswire/ - The GLOBAL ... service for,business executives in pharmaceutical and life ... and other industries,launches a Virtual Tour of ... COUNCIL service by visiting, http://www3.best-in-class.com/gr148.htm or ...
... avoid heart disease, cancer, task force report says , , ... skin disease psoriasis, long known to negatively affect a ... with more serious conditions such as cardiovascular disease and ... study, published online in the Journal of the ...
... 3, 2008 The International Neuroinformatics Coordinating Facility ... wide adoption of the Neuroscience Peer Review Consortium ... neuroscience journals that have agreed to accept manuscript ... accelerate publication of research articles. Currently, 27 journals ...
... and external ... pediatric heart pumps, PITTSBURGH, April 3, ... in the use of lifesaving,ventricular assist devices (VADs) for children in ... awarded a $2.3 million grant from,the National Institutes of Health (NIH) ...
Other Medicine News:Health News:Voting for Clinton Evokes Deep-Seated Feelings of Insecurity 2Health News:MetLife Foundation Awards $815,000 to Alzheimer's Association for Hispanic Outreach and Safety Initiatives 2Health News:MetLife Foundation Awards $815,000 to Alzheimer's Association for Hispanic Outreach and Safety Initiatives 3Health News:Global Benchmarking Council Launches New Virtual Tour of Research & Networking Service 2Health News:Psoriasis Poses Danger for More Serious Complications 2Health News:Neuroscience Peer Review Consortium announces increased journal participation 2Health News:Children's Hospital of Pittsburgh of UPMC Involved in Projects To Develop Nation's First Heart Assist Devices for Young Children 2Health News:Children's Hospital of Pittsburgh of UPMC Involved in Projects To Develop Nation's First Heart Assist Devices for Young Children 3
Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
Used for percutaneous nephrostomy. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: